mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.07 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.07 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.08 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |